Home
>
US Stocks
>
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN

Regeneron Pharmaceuticals, Inc.

$543.6118.35%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
552.65
Today Low/High
539.36 / 552.65
52 Week Low/High
$441 / $650
P/E ratio
10.97
Market Cap
$68.05B

Company Details

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, its unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in its laboratories. Its medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.
Organisation
Regeneron Pharmaceuticals, Inc.
Headquaters
Tarrytown, New York, United States
Employees
9.12K
Industry
Health Technology
CEO
Leonard Schleifer
Company Financials
  • Annual P&L
  • Quarterly P&L

Discover more

Frequently Asked Questions

What is Regeneron Pharmaceuticals, Inc. share price today

Can Indians buy Regeneron Pharmaceuticals, Inc. shares?

How can I buy Regeneron Pharmaceuticals, Inc. shares from India?

Can Fractional shares of Regeneron Pharmaceuticals, Inc. be purchased?

What are the documents required to start investing in Regeneron Pharmaceuticals, Inc. stocks?

We are a SEBI registered investement advisor